Stay updated on Nivolumab/Ipilimumab + Chemo vs Chemo Alone Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab + Chemo vs Chemo Alone Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab + Chemo vs Chemo Alone Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no substantive changes to the record content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.4.1 was added; the lapse in government funding notice and Revision: v3.4.0 were removed.SummaryDifference0.4%

- Check22 days agoChange DetectedA site-wide banner noting a lapse in government funding and NIH Clinical Center status has been added, with links for updates. This change does not affect the study record data presented on the page.SummaryDifference0.4%

- Check29 days agoChange DetectedGlossary is now shown and changes are color-coded (green for additions, red for deletions) with a new revision label (v3.4.0) reflected on the history page.SummaryDifference0.5%

- Check36 days agoChange DetectedThe history now includes a new Revision: v3.3.4 entry, and Revision: v3.3.3 is removed from the list.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded core study data sections: Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Outcome Measures, and Study Status (Revision: v3.3.3, 2025-12-17). Removed the HHS Vulnerability Disclosure section in the 2024-12-24 revision (Revision: v3.3.2).SummaryDifference0.6%

Stay in the know with updates to Nivolumab/Ipilimumab + Chemo vs Chemo Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab + Chemo vs Chemo Alone Clinical Trial page.